Atrial fibrillation in patient with high thrombotic risk: which therapy?


View Publication Info
Field Value
Title Atrial fibrillation in patient with high thrombotic risk: which therapy?
Creator Dell'Era, Gabriele
Description We report the case of an elderly patient suffering for about 20 years of hypertensive cardiac hypertrophy, carotid and peripheral vasculopathy. The patient, initially treated with oral anticoagulant therapy (dicumarol) due to relapsing atrial fibrillation, is an example of long-term use of dabigatran, dictated by safety concern in a patient at high risk of bleeding: as demonstrated by the RE-LY trial, dabigatran 110 mg / day has a preventive effect on cerebral events similar warfarin but with a lower incidence of bleeding. In this case, at high risk both thrombotic and hemorrhagic, the choice of dabigatran was successful in the long term (Cardiology).
Publisher Aboutscience Srl
Date 2018-10-24
Type info:eu-repo/semantics/article
Case report
Format application/pdf
Source AboutOpen; V. 4 N. 1 (2018): January - December 2018; 174-178
AboutOpen; Vol 4 No 1 (2018): January - December 2018; 174-178
Language eng
Rights Copyright (c) 2018 The authors

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us


Copyright © 2015-2018 Simon Fraser University Library